5-[4-[(2-amino-4-pyridinyl)oxy]phenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;5-[4-(7-methoxyquinazolin-4-yl)oxyphenyl]-N-[3-(trifluoromethyl)phenyl]-1H-1,2,4-triazol-3-amine;5-[4-(7-methoxyquinolin-4-yl)oxyphenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;4-[4-[5-(3-methylanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyridine-3-sulfonamide;4-[4-[3-(3-methylanilino)-1H-1,2,4-triazol-5-yl]phenoxy]quinolin-2-amine;N-(3-methylphenyl)-5-[4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]-1H-1,2,4-triazol-3-amine;N-(3-methylphenyl)-5-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yloxy)phenyl]-1,3,4-oxadiazol-2-amine;N-(3-methylphenyl)-5-(4-quinolin-4-yloxyphenyl)-1,3,4-oxadiazol-2-amine

C180H143F3N42O17S — CID 157422625

About 5-[4-[(2-amino-4-pyridinyl)oxy]phenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;5-[4-(7-methoxyquinazolin-4-yl)oxyphenyl]-N-[3-(trifluoromethyl)phenyl]-1H-1,2,4-triazol-3-amine;5-[4-(7-methoxyquinolin-4-yl)oxyphenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;4-[4-[5-(3-methylanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyridine-3-sulfonamide;4-[4-[3-(3-methylanilino)-1H-1,2,4-triazol-5-yl]phenoxy]quinolin-2-amine;N-(3-methylphenyl)-5-[4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]-1H-1,2,4-triazol-3-amine;N-(3-methylphenyl)-5-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yloxy)phenyl]-1,3,4-oxadiazol-2-amine;N-(3-methylphenyl)-5-(4-quinolin-4-yloxyphenyl)-1,3,4-oxadiazol-2-amine

5-[4-[(2-amino-4-pyridinyl)oxy]phenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;5-[4-(7-methoxyquinazolin-4-yl)oxyphenyl]-N-[3-(trifluoromethyl)phenyl]-1H-1,2,4-triazol-3-amine;5-[4-(7-methoxyquinolin-4-yl)oxyphenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;4-[4-[5-(3-methylanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyridine-3-sulfonamide;4-[4-[3-(3-methylanilino)-1H-1,2,4-triazol-5-yl]phenoxy]quinolin-2-amine;N-(3-methylphenyl)-5-[4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]-1H-1,2,4-triazol-3-amine;N-(3-methylphenyl)-5-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yloxy)phenyl]-1,3,4-oxadiazol-2-amine;N-(3-methylphenyl)-5-(4-quinolin-4-yloxyphenyl)-1,3,4-oxadiazol-2-amine (PubChem CID 157422625) has the molecular formula C180H143F3N42O17S and a molecular weight of 3255.46 g/mol. Its IUPAC name is 5-[4-[(2-amino-4-pyridinyl)oxy]phenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;5-[4-(7-methoxyquinazolin-4-yl)oxyphenyl]-N-[3-(trifluoromethyl)phenyl]-1H-1,2,4-triazol-3-amine;5-[4-(7-methoxyquinolin-4-yl)oxyphenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;4-[4-[5-(3-methylanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyridine-3-sulfonamide;4-[4-[3-(3-methylanilino)-1H-1,2,4-triazol-5-yl]phenoxy]quinolin-2-amine;N-(3-methylphenyl)-5-[4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]-1H-1,2,4-triazol-3-amine;N-(3-methylphenyl)-5-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yloxy)phenyl]-1,3,4-oxadiazol-2-amine;N-(3-methylphenyl)-5-(4-quinolin-4-yloxyphenyl)-1,3,4-oxadiazol-2-amine.

Molecular Properties

• Compound Name: 5-[4-[(2-amino-4-pyridinyl)oxy]phenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;5-[4-(7-methoxyquinazolin-4-yl)oxyphenyl]-N-[3-(trifluoromethyl)phenyl]-1H-1,2,4-triazol-3-amine;5-[4-(7-methoxyquinolin-4-yl)oxyphenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;4-[4-[5-(3-methylanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyridine-3-sulfonamide;4-[4-[3-(3-methylanilino)-1H-1,2,4-triazol-5-yl]phenoxy]quinolin-2-amine;N-(3-methylphenyl)-5-[4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]-1H-1,2,4-triazol-3-amine;N-(3-methylphenyl)-5-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yloxy)phenyl]-1,3,4-oxadiazol-2-amine;N-(3-methylphenyl)-5-(4-quinolin-4-yloxyphenyl)-1,3,4-oxadiazol-2-amine
• PubChem CID: 157422625
• Molecular Formula: C180H143F3N42O17S
• Molecular Weight: 3255.46 g/mol
• Exact Mass: 3253.13
• IUPAC Name: 5-[4-[(2-amino-4-pyridinyl)oxy]phenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;5-[4-(7-methoxyquinazolin-4-yl)oxyphenyl]-N-[3-(trifluoromethyl)phenyl]-1H-1,2,4-triazol-3-amine;5-[4-(7-methoxyquinolin-4-yl)oxyphenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;4-[4-[5-(3-methylanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyridine-3-sulfonamide;4-[4-[3-(3-methylanilino)-1H-1,2,4-triazol-5-yl]phenoxy]quinolin-2-amine;N-(3-methylphenyl)-5-[4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]-1H-1,2,4-triazol-3-amine;N-(3-methylphenyl)-5-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yloxy)phenyl]-1,3,4-oxadiazol-2-amine;N-(3-methylphenyl)-5-(4-quinolin-4-yloxyphenyl)-1,3,4-oxadiazol-2-amine
• SMILES: COc1ccc2c(Oc3ccc(-c4nc(Nc5cccc(C(F)(F)F)c5)n[nH]4)cc3)ncnc2c1.COc1ccc2c(Oc3ccc(-c4nnc(Nc5cccc(C)c5)o4)cc3)ccnc2c1.Cc1cccc(Nc2n[nH]c(-c3ccc(Oc4cc(N)nc5ccccc45)cc3)n2)c1.Cc1cccc(Nc2n[nH]c(-c3ccc(Oc4ccnc5[nH]ccc45)cc3)n2)c1.Cc1cccc(Nc2nnc(-c3ccc(Oc4ccnc(N)c4)cc3)o2)c1.Cc1cccc(Nc2nnc(-c3ccc(Oc4ccnc5ccccc45)cc3)o2)c1.Cc1cccc(Nc2nnc(-c3ccc(Oc4ccncc4S(N)(=O)=O)cc3)o2)c1.Cc1cccc(Nc2nnc(-c3ccc(Oc4ncnc5[nH]ccc45)cc3)o2)c1
• InChI: InChI=1S/C25H20N4O3.C24H17F3N6O2.C24H20N6O.C24H18N4O2.C22H18N6O.C21H16N6O2.C20H17N5O4S.C20H17N5O2/c1-16-4-3-5-18(14-16)27-25-29-28-24(32-25)17-6-8-19(9-7-17)31-23-12-13-26-22-15-20(30-2)10-11-21(22)23;1-34-18-9-10-19-20(12-18)28-13-29-22(19)35-17-7-5-14(6-8-17)21-31-23(33-32-21)30-16-4-2-3-15(11-16)24(25,26)27;1-15-5-4-6-17(13-15)26-24-28-23(29-30-24)16-9-11-18(12-10-16)31-21-14-22(25)27-20-8-3-2-7-19(20)21;1-16-5-4-6-18(15-16)26-24-28-27-23(30-24)17-9-11-19(12-10-17)29-22-13-14-25-21-8-3-2-7-20(21)22;1-14-3-2-4-16(13-14)25-22-26-20(27-28-22)15-5-7-17(8-6-15)29-19-10-12-24-21-18(19)9-11-23-21;1-13-3-2-4-15(11-13)25-21-27-26-19(29-21)14-5-7-16(8-6-14)28-20-17-9-10-22-18(17)23-12-24-20;1-13-3-2-4-15(11-13)23-20-25-24-19(29-20)14-5-7-16(8-6-14)28-17-9-10-22-12-18(17)30(21,26)27;1-13-3-2-4-15(11-13)23-20-25-24-19(27-20)14-5-7-16(8-6-14)26-17-9-10-22-18(21)12-17/h3-15H,1-2H3,(H,27,29);2-13H,1H3,(H2,30,31,32,33);2-14H,1H3,(H2,25,27)(H2,26,28,29,30);2-15H,1H3,(H,26,28);2-13H,1H3,(H,23,24)(H2,25,26,27,28);2-12H,1H3,(H,25,27)(H,22,23,24);2-12H,1H3,(H,23,25)(H2,21,26,27);2-12H,1H3,(H2,21,22)(H,23,25)
• InChIKey: BPOXOGPIESVZHX-UHFFFAOYSA-N
• XLogP: 41.92
• TPSA: 780.53 Ų
• H-Bond Donors: 16
• H-Bond Acceptors: 53
• Rotatable Bonds: 43
• Heavy Atoms: 243
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	3255.46
LogP ≤ 5	41.92
H-Bond Donors ≤ 5	16
H-Bond Acceptors ≤ 10	53

Frequently Asked Questions

What is the IUPAC name of 5-[4-[(2-amino-4-pyridinyl)oxy]phenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;5-[4-(7-methoxyquinazolin-4-yl)oxyphenyl]-N-[3-(trifluoromethyl)phenyl]-1H-1,2,4-triazol-3-amine;5-[4-(7-methoxyquinolin-4-yl)oxyphenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;4-[4-[5-(3-methylanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyridine-3-sulfonamide;4-[4-[3-(3-methylanilino)-1H-1,2,4-triazol-5-yl]phenoxy]quinolin-2-amine;N-(3-methylphenyl)-5-[4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]-1H-1,2,4-triazol-3-amine;N-(3-methylphenyl)-5-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yloxy)phenyl]-1,3,4-oxadiazol-2-amine;N-(3-methylphenyl)-5-(4-quinolin-4-yloxyphenyl)-1,3,4-oxadiazol-2-amine?

The IUPAC name of 5-[4-[(2-amino-4-pyridinyl)oxy]phenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;5-[4-(7-methoxyquinazolin-4-yl)oxyphenyl]-N-[3-(trifluoromethyl)phenyl]-1H-1,2,4-triazol-3-amine;5-[4-(7-methoxyquinolin-4-yl)oxyphenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;4-[4-[5-(3-methylanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyridine-3-sulfonamide;4-[4-[3-(3-methylanilino)-1H-1,2,4-triazol-5-yl]phenoxy]quinolin-2-amine;N-(3-methylphenyl)-5-[4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]-1H-1,2,4-triazol-3-amine;N-(3-methylphenyl)-5-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yloxy)phenyl]-1,3,4-oxadiazol-2-amine;N-(3-methylphenyl)-5-(4-quinolin-4-yloxyphenyl)-1,3,4-oxadiazol-2-amine (CID 157422625) is 5-[4-[(2-amino-4-pyridinyl)oxy]phenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;5-[4-(7-methoxyquinazolin-4-yl)oxyphenyl]-N-[3-(trifluoromethyl)phenyl]-1H-1,2,4-triazol-3-amine;5-[4-(7-methoxyquinolin-4-yl)oxyphenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;4-[4-[5-(3-methylanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyridine-3-sulfonamide;4-[4-[3-(3-methylanilino)-1H-1,2,4-triazol-5-yl]phenoxy]quinolin-2-amine;N-(3-methylphenyl)-5-[4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]-1H-1,2,4-triazol-3-amine;N-(3-methylphenyl)-5-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yloxy)phenyl]-1,3,4-oxadiazol-2-amine;N-(3-methylphenyl)-5-(4-quinolin-4-yloxyphenyl)-1,3,4-oxadiazol-2-amine.

What is the SMILES notation for 5-[4-[(2-amino-4-pyridinyl)oxy]phenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;5-[4-(7-methoxyquinazolin-4-yl)oxyphenyl]-N-[3-(trifluoromethyl)phenyl]-1H-1,2,4-triazol-3-amine;5-[4-(7-methoxyquinolin-4-yl)oxyphenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;4-[4-[5-(3-methylanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyridine-3-sulfonamide;4-[4-[3-(3-methylanilino)-1H-1,2,4-triazol-5-yl]phenoxy]quinolin-2-amine;N-(3-methylphenyl)-5-[4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]-1H-1,2,4-triazol-3-amine;N-(3-methylphenyl)-5-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yloxy)phenyl]-1,3,4-oxadiazol-2-amine;N-(3-methylphenyl)-5-(4-quinolin-4-yloxyphenyl)-1,3,4-oxadiazol-2-amine?

The canonical SMILES for 5-[4-[(2-amino-4-pyridinyl)oxy]phenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;5-[4-(7-methoxyquinazolin-4-yl)oxyphenyl]-N-[3-(trifluoromethyl)phenyl]-1H-1,2,4-triazol-3-amine;5-[4-(7-methoxyquinolin-4-yl)oxyphenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;4-[4-[5-(3-methylanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyridine-3-sulfonamide;4-[4-[3-(3-methylanilino)-1H-1,2,4-triazol-5-yl]phenoxy]quinolin-2-amine;N-(3-methylphenyl)-5-[4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]-1H-1,2,4-triazol-3-amine;N-(3-methylphenyl)-5-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yloxy)phenyl]-1,3,4-oxadiazol-2-amine;N-(3-methylphenyl)-5-(4-quinolin-4-yloxyphenyl)-1,3,4-oxadiazol-2-amine is COc1ccc2c(Oc3ccc(-c4nc(Nc5cccc(C(F)(F)F)c5)n[nH]4)cc3)ncnc2c1.COc1ccc2c(Oc3ccc(-c4nnc(Nc5cccc(C)c5)o4)cc3)ccnc2c1.Cc1cccc(Nc2n[nH]c(-c3ccc(Oc4cc(N)nc5ccccc45)cc3)n2)c1.Cc1cccc(Nc2n[nH]c(-c3ccc(Oc4ccnc5[nH]ccc45)cc3)n2)c1.Cc1cccc(Nc2nnc(-c3ccc(Oc4ccnc(N)c4)cc3)o2)c1.Cc1cccc(Nc2nnc(-c3ccc(Oc4ccnc5ccccc45)cc3)o2)c1.Cc1cccc(Nc2nnc(-c3ccc(Oc4ccncc4S(N)(=O)=O)cc3)o2)c1.Cc1cccc(Nc2nnc(-c3ccc(Oc4ncnc5[nH]ccc45)cc3)o2)c1.

What is the InChIKey of 5-[4-[(2-amino-4-pyridinyl)oxy]phenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;5-[4-(7-methoxyquinazolin-4-yl)oxyphenyl]-N-[3-(trifluoromethyl)phenyl]-1H-1,2,4-triazol-3-amine;5-[4-(7-methoxyquinolin-4-yl)oxyphenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;4-[4-[5-(3-methylanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyridine-3-sulfonamide;4-[4-[3-(3-methylanilino)-1H-1,2,4-triazol-5-yl]phenoxy]quinolin-2-amine;N-(3-methylphenyl)-5-[4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]-1H-1,2,4-triazol-3-amine;N-(3-methylphenyl)-5-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yloxy)phenyl]-1,3,4-oxadiazol-2-amine;N-(3-methylphenyl)-5-(4-quinolin-4-yloxyphenyl)-1,3,4-oxadiazol-2-amine?

The InChIKey is BPOXOGPIESVZHX-UHFFFAOYSA-N. The full InChI is InChI=1S/C25H20N4O3.C24H17F3N6O2.C24H20N6O.C24H18N4O2.C22H18N6O.C21H16N6O2.C20H17N5O4S.C20H17N5O2/c1-16-4-3-5-18(14-16)27-25-29-28-24(32-25)17-6-8-19(9-7-17)31-23-12-13-26-22-15-20(30-2)10-11-21(22)23;1-34-18-9-10-19-20(12-18)28-13-29-22(19)35-17-7-5-14(6-8-17)21-31-23(33-32-21)30-16-4-2-3-15(11-16)24(25,26)27;1-15-5-4-6-17(13-15)26-24-28-23(29-30-24)16-9-11-18(12-10-16)31-21-14-22(25)27-20-8-3-2-7-19(20)21;1-16-5-4-6-18(15-16)26-24-28-27-23(30-24)17-9-11-19(12-10-17)29-22-13-14-25-21-8-3-2-7-20(21)22;1-14-3-2-4-16(13-14)25-22-26-20(27-28-22)15-5-7-17(8-6-15)29-19-10-12-24-21-18(19)9-11-23-21;1-13-3-2-4-15(11-13)25-21-27-26-19(29-21)14-5-7-16(8-6-14)28-20-17-9-10-22-18(17)23-12-24-20;1-13-3-2-4-15(11-13)23-20-25-24-19(29-20)14-5-7-16(8-6-14)28-17-9-10-22-12-18(17)30(21,26)27;1-13-3-2-4-15(11-13)23-20-25-24-19(27-20)14-5-7-16(8-6-14)26-17-9-10-22-18(21)12-17/h3-15H,1-2H3,(H,27,29);2-13H,1H3,(H2,30,31,32,33);2-14H,1H3,(H2,25,27)(H2,26,28,29,30);2-15H,1H3,(H,26,28);2-13H,1H3,(H,23,24)(H2,25,26,27,28);2-12H,1H3,(H,25,27)(H,22,23,24);2-12H,1H3,(H,23,25)(H2,21,26,27);2-12H,1H3,(H2,21,22)(H,23,25).

What are the key properties of 5-[4-[(2-amino-4-pyridinyl)oxy]phenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;5-[4-(7-methoxyquinazolin-4-yl)oxyphenyl]-N-[3-(trifluoromethyl)phenyl]-1H-1,2,4-triazol-3-amine;5-[4-(7-methoxyquinolin-4-yl)oxyphenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;4-[4-[5-(3-methylanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyridine-3-sulfonamide;4-[4-[3-(3-methylanilino)-1H-1,2,4-triazol-5-yl]phenoxy]quinolin-2-amine;N-(3-methylphenyl)-5-[4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]-1H-1,2,4-triazol-3-amine;N-(3-methylphenyl)-5-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yloxy)phenyl]-1,3,4-oxadiazol-2-amine;N-(3-methylphenyl)-5-(4-quinolin-4-yloxyphenyl)-1,3,4-oxadiazol-2-amine?

5-[4-[(2-amino-4-pyridinyl)oxy]phenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;5-[4-(7-methoxyquinazolin-4-yl)oxyphenyl]-N-[3-(trifluoromethyl)phenyl]-1H-1,2,4-triazol-3-amine;5-[4-(7-methoxyquinolin-4-yl)oxyphenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;4-[4-[5-(3-methylanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyridine-3-sulfonamide;4-[4-[3-(3-methylanilino)-1H-1,2,4-triazol-5-yl]phenoxy]quinolin-2-amine;N-(3-methylphenyl)-5-[4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]-1H-1,2,4-triazol-3-amine;N-(3-methylphenyl)-5-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yloxy)phenyl]-1,3,4-oxadiazol-2-amine;N-(3-methylphenyl)-5-(4-quinolin-4-yloxyphenyl)-1,3,4-oxadiazol-2-amine has a molecular weight of 3255.46 g/mol, XLogP of 41.92, 43 rotatable bonds, 16 hydrogen bond donors, and 53 hydrogen bond acceptors.

Where does this data come from?

All data for 5-[4-[(2-amino-4-pyridinyl)oxy]phenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;5-[4-(7-methoxyquinazolin-4-yl)oxyphenyl]-N-[3-(trifluoromethyl)phenyl]-1H-1,2,4-triazol-3-amine;5-[4-(7-methoxyquinolin-4-yl)oxyphenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;4-[4-[5-(3-methylanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyridine-3-sulfonamide;4-[4-[3-(3-methylanilino)-1H-1,2,4-triazol-5-yl]phenoxy]quinolin-2-amine;N-(3-methylphenyl)-5-[4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]-1H-1,2,4-triazol-3-amine;N-(3-methylphenyl)-5-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yloxy)phenyl]-1,3,4-oxadiazol-2-amine;N-(3-methylphenyl)-5-(4-quinolin-4-yloxyphenyl)-1,3,4-oxadiazol-2-amine is sourced from PubChem (CID 157422625), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).